Drug exposure during breastfeeding: a descriptive population-based cohort study with SIDIAP database
Maria Giner-Soriano, Guim Arbona Ricart, Àurea Cartanyà-Hueso, Ainhoa Gomez-Lumbreras, Marta Lestón Vázquez, Rosa Morros, Cristina Vedia · 2025
Read Drug exposure during breastfeeding: a descriptive population-based cohort study with SIDIAP database by Maria Giner-Soriano, Guim Arbona Ricart, Àurea Cartanyà-Hueso, Ainhoa Gomez-Lumbreras, Marta Lestón Vázquez, Rosa Morros, Cristina Vedia (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12849492.txt.
Description
Maria Giner-Soriano and six co-authors mapped which drugs mothers take while breastfeeding, in this 2025 study from Catalonia, Spain. Nursing mothers are shut out of most drug trials, so real-world proof is scarce. The team linked health records for more than 176,000 mother and baby pairs with nursing noted in the child's file, covering births from 2010 to 2022.
By the first birthday, the share still nursing fell to about thirty-six percent. Drug use was common early on: about forty-three percent of mothers took something in the first two months. Iron, folic acid, and pain drugs topped the list, with paracetamol the single most given drug. The authors say such record studies can fill the proof gap that trials leave behind.
Catalog record
| CREATOR | Maria Giner-Soriano, Guim Arbona Ricart, Àurea Cartanyà-Hueso, Ainhoa Gomez-Lumbreras, Marta Lestón Vázquez, Rosa Morros, Cristina Vedia |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 27 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |